16 September 2026 editorial review · Item
DIA:CONN P8 smart insulin pen: review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Thriving evidence review — 16 September 2026
Record: DIA:CONN P8 smart insulin pen
Scope and findings:
- Read manufacturer capacity/increments and full retrospective42-person study. Both groups received intensive education; 21 SIP users improved TIR 47.8 to 70.8, nonrandomized confounding limits device-only attribution. Separate registered randomized trial results not established.
Primary sources checked:
Limits: The review is restricted to the scopes above. Historical efficacy estimates, editorial scoring and country-specific access were not fully reverified unless expressly stated. A manufacturer or conference report retains that evidence level.